Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2011, Vol. 12 Issue (9): 712-719    DOI: 10.1631/jzus.B1000362
Articles     
Hyaluronic acid as a rescue therapy for trinitrobenzene sulfonic acid-induced colitis through Cox-2 and PGE2 in a Toll-like receptor 4-dependent way
Huan Chen, Mahesh Mahaseth, Yan Zhang
Department of Gastroenterology, West China Hospital of Sichuan University, Chengdu 610041, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  We hypothesized whether systemic administration of high-molecular-weight hyaluronic acid (HMW HA) could rescue trinitrobenzene sulfonic acid (TNBS)-induced colitis through Toll-like receptor 4 (TLR4) signal. C3H/HeN mice and C3H/HeJ mice were used. Mice were divided into four groups: control, 50% ethanol treatment group, TNBS treatment group, and TNBS plus HA treatment group. The weight changes, clinical scores, macroscopic scores, and histological scores were recorded. Cyclooxygenase 2 (Cox-2) and prostaglandin E2 (PGE2) expressions were measured both in colons and peritoneal macrophages from these mice. HA was a rescue therapy for the colitis induced by TNBS only in C3H/HeN mice. The clinical score, macroscopic score, and histological score were much lower in C3H/HeN mice receiving TNBS plus HA treatment. Cox-2 and PGE2 expressions only increased in C3H/HeN mice. These Cox-2 expressing cells were macrophages. HA can also promote the production of Cox-2 and PGE2 in peritoneal macrophages from C3H/HeN mice. Our data demonstrated that HMW HA can rescue TNBS-induced colitis through inducing Cox-2 and PGE2 expressions in a TLR4-dependent way. Macrophages may be the effector cells of HMW HA.

Key wordsTrinitrobenzene sulfonic acid (TNBS) colitis      Therapy      Hyaluronic acid      Toll-like receptor     
Received: 17 October 2010     
CLC:  R574.6  
Cite this article:

Huan Chen, Mahesh Mahaseth, Yan Zhang. Hyaluronic acid as a rescue therapy for trinitrobenzene sulfonic acid-induced colitis through Cox-2 and PGE2 in a Toll-like receptor 4-dependent way. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(9): 712-719.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1000362     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2011/V12/I9/712

[1] Meng-wen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng, Lei Zheng. DNA methylation in the tumor microenvironment[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(5): 365-372.
[2] Ming Zhao, Xian-feng Ding, Jian-yu Shen, Xi-ping Zhang, Xiao-wen Ding, Bin Xu. Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 15-26.
[3] Chun-xi Wang, Shu-li Guo, Li-na Han. Successful treatment of accessory breast cancer with endocrine therapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 70-75.
[4] Yang Guo, Bo Chen, Li-jun Chen, Chun-feng Zhang, Charlie Xiang. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(11): 831-841.
[5] Xu-wei Luo, Kang Liu, Zhu Chen, Ming Zhao, Xiao-wei Han, Yi-guang Bai, Gang Feng. Adenovirus-mediated GDF-5 promotes the extracellular matrix expression in degenerative nucleus pulposus cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(1): 30-42.
[6] Xiao-peng Lan, You-gen Chen, Zheng Wang, Chuan-wei Yuan, Gang-gang Wang, Guo-liang Lu, Shao-wei Mao, Xun-bo Jin, Qing-hua Xia. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(9): 743-756.
[7] Hui-ying Wang, Yi-hong Shen, Xu-yan Yang, Lan-fang Tang, Jian-ying Zhou, on behalf of the Zhejiang Provincial Academy of Allergy . Diagnosis and treatment of allergic diseases in Zhejiang Province: a cross-sectional survey[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(7): 640-650.
[8] Xinguo Jiang. Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 44-45.
[9] Wei Wang, Yun-ping Luo. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 18-31.
[10] You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 756-760.
[11] Chai-Hong Yeong, Mu-hua Cheng, Kwan-Hoong Ng. Therapeutic radionuclides in nuclear medicine: current and future prospects[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(10): 845-863.
[12] Xinguo Jiang. Harnessing the immune system for the treatment of breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 1-15.
[13] Hai-ying Xu, Yi-zhou Xu, Feng Ling, Zhong Yu, Jun Yang, Xu Duan, Bei Wang, Jin-yu Huang. Application of CRT-D in a Marfan syndrome patient with chronic heart failure accompanied by ventricular tachycardia and ventricular fibrillation[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(8): 759-762.
[14] Yan Jiang, Jing Zhao, Hui-jing Qi, Xiao-lin Li, Shi-rong Zhang, Daniel W. Song, Chi-yang Yu, Jian-gang Gao. Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(4): 318-324.
[15] Wen-hua Ruan, Mei-li Huang, Xiao-lei He, Feng Zhang, Hai-biao Tao. Effects of Huangqi and bear bile on recurrent parotitis in children: a new clinical approach[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(3): 253-258.